Published in Blood Weekly, November 18th, 1996
Leukine, a yeast-expressed granulocyte-macrophage colony stimulating factor (GM-CSF), has been available in the United States since 1991. "This new approval substantially upgrades Leukine's marketability and broadens its customer appeal," said Len Stevens, Immunex. "For the first time, Leukine has a competitive advantage, offering customers a choice of dosage forms including the new multi-use product."
"Leukine Liquid will provide a generally safe, more convenient product for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.